130 related articles for article (PubMed ID: 32926150)
1. Antifungal effect of anthraquinones against Cryptococcus neoformans: detection of synergism with amphotericin B.
Brilhante RSN; Araújo GDS; Fonseca XMQC; Guedes GMM; Aguiar L; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Pereira Neto WA; Rocha MFG
Med Mycol; 2020 Sep; ():. PubMed ID: 32926150
[TBL] [Abstract][Full Text] [Related]
2. Anthraquinones against
Araújo GDS; Brilhante RSN; Rocha MGD; Aguiar L; Castelo-Branco DSCM; Guedes GMM; Sidrim JJC; Pereira Neto WA; Rocha MFG
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38530134
[No Abstract] [Full Text] [Related]
3. Anthraquinones from
de Souza Collares Maia Castelo-Branco D; Dos Santos Araújo G; Fonseca XMQC; de Melo Guedes GM; da Rocha MG; Brilhante RSN; de Aguiar Cordeiro R; Sidrim JJC; Pereira-Neto WA; Rocha MFG
Biofouling; 2021 Sep; 37(8):809-817. PubMed ID: 34634964
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans.
Tan L; Shi H; Chen M; Wang Z; Yao Z; Sun Y
J Mycol Med; 2022 Mar; 32(1):101227. PubMed ID: 34800920
[TBL] [Abstract][Full Text] [Related]
5. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains.
Scalas D; Mandras N; Roana J; Tardugno R; Cuffini AM; Ghisetti V; Benvenuti S; Tullio V
BMC Complement Altern Med; 2018 May; 18(1):143. PubMed ID: 29724221
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of pyrvinium pamoate and posaconazole against
Li Y; Li S; Chen M; Xiao J; Fang H
Front Cell Infect Microbiol; 2022; 12():1074903. PubMed ID: 36569209
[TBL] [Abstract][Full Text] [Related]
7. Interactions between antifungals and everolimus against
Liang P; Song J; Liu Q
Front Cell Infect Microbiol; 2023; 13():1131641. PubMed ID: 37026056
[TBL] [Abstract][Full Text] [Related]
8. Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin.
Alves DS; Pérez-Fons L; Estepa A; Micol V
Biochem Pharmacol; 2004 Aug; 68(3):549-61. PubMed ID: 15242821
[TBL] [Abstract][Full Text] [Related]
9.
Al-Odaini N; Li XY; Li BK; Chen XC; Huang CY; Lv CY; Pan KS; Zheng DY; Zheng YQ; Liao WQ; Cao CW
Front Microbiol; 2021; 12():708280. PubMed ID: 34447360
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
11. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
Franzot SP; Casadevall A
Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
[TBL] [Abstract][Full Text] [Related]
12. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
Brilhante RSN; Rocha MGD; Oliveira JS; Pereira-Neto WA; Guedes GMM; Cordeiro RA; Sidrim JJC; Rocha MFG; Castelo-Branco DSCM
Microb Pathog; 2020 Jun; 143():104123. PubMed ID: 32169493
[TBL] [Abstract][Full Text] [Related]
14. Synergic effect of simvastatin in combination with amphotericin B against environmental strains of Cryptococcus neoformans from northeastern Brazil: a prospective experimental study.
Silva THS; Araújo CV; Santos KMDC; Alves NDS; Gomes THS; Silva AKFE; Silva NCLDS; Damasceno Júnior ECB; Carvalho AMA; Mendes MGA; Caminha HB; Daboit TC; Ferreira TB; Andrade-Silva LE; Silva-Vergara ML; Ferreira-Paim K; Fonseca FM
Sao Paulo Med J; 2020; 138(1):40-46. PubMed ID: 32321104
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination and pharmacokinetic studies of aloe emodin and chrysophanol in rats after oral administration of Da-Cheng-Qi decoction by high-performance liquid chromatography.
Tang WF; Yu Q; Wan MH; Qin F; Wang YG; Chen GY; Liang MZ; Huang X
Biomed Chromatogr; 2007 Jul; 21(7):701-7. PubMed ID: 17370297
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of anthraquinones on the purgative activity of rhein anthrone in mice.
Yagi T; Yamauchi K
J Pharm Pharmacol; 1999 Jan; 51(1):93-5. PubMed ID: 10197424
[TBL] [Abstract][Full Text] [Related]
17. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
[TBL] [Abstract][Full Text] [Related]
18. A purgative action of barbaloin is induced by Eubacterium sp. strain BAR, a human intestinal anaerobe, capable of transforming barbaloin to aloe-emodin anthrone.
Akao T; Che QM; Kobashi K; Hattori M; Namba T
Biol Pharm Bull; 1996 Jan; 19(1):136-8. PubMed ID: 8820926
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Yang JH; Huang PY; Cheng CW; Shie SS; Lin ZF; Yang LY; Lee CH; Wu TS
Med Mycol; 2021 Nov; 59(11):1114-1121. PubMed ID: 34374784
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
